Table 3.
Univariate and multivariate analysis for atrial fibrillation recurrence after ablation
|
Variables |
Univariate analysis |
Multivariate analysis |
||||
|---|---|---|---|---|---|---|
| OR | 95% CI | p value | OR | 95% CI | p value | |
| Age (years) |
1.009 |
0.951-1.071 |
0.758 |
|
|
|
| Gender (male) |
0.935 |
0.337-2.579 |
0.897 |
|
|
|
|
Persistent AF |
3.794 |
1.350-10.659 |
0.011 |
|
|
|
| Duration of AF (months) |
1.005 |
0.998-1.012 |
0.189 |
|
|
|
|
Left atrial diameter (mm) |
1.108 |
1.002-1.225 |
0.045 |
|
|
|
| LVEF (%) |
1.047 |
0.961-1.141 |
0.289 |
|
|
|
|
NT-proBNP |
1.001 |
1.000-1.002 |
0.007 |
|
|
|
| Anti-M2-R |
|
|
|
|
|
|
| Titer |
4.252 |
1.913-6.591 |
<0.001 |
2.339 |
1.509-3.626 |
<0.001 |
| Frequency | 5.500 | 1.880-16.091 | 0.002 | 4.701 | 1.590-13.894 | 0.005 |
Abbreviations: OR=odds ratio, CI=confidence interval, AF=atrial fibrillation, LVEF=left ventricular ejection fraction, NT-proBNP = N-terminal pro-brain natriuretic peptide, anti-M2-R = autoantibody against muscarinic-2 acetylcholine receptor.